
Artemis Medicare Services Q2 Results FY27: Revenue Up 13.23% to Rs 311.04 Cr, PAT Rs 31.1 Cr
Updated: 30 Oct 2026 • 11:53 pm
Posted by:

Quick Answer
Artemis Medicare Services Q2 Results FY27 were declared on 30 October 2026, and the quarterly results show Consolidated revenue of Rs 311.04 Cr, up 13.23% from Rs 274.7 Cr a year earlier. Net profit was Rs 31.1 Cr against Rs 30 Cr, a YoY growth of 3.67%. Operating Profit stood at Rs 54.82 Cr, up 8.3% YoY. All figures cover the July to September 2026 quarter.
Artemis Medicare Services Ltd (ARTEMISMED) Q2 Results FY27 announced on 30 October 2026, covering the company's financial performance for the July to September quarter. The company reported consolidated revenue of Rs 311.04 Cr and PAT of Rs 31.1 Cr. The Artemis Medicare Services Q2 Results FY27 release gives the results date and the consolidated results in one filing.
This Artemis Medicare Services Q2 Results results analysis covers the financial highlights, the business drivers named in the disclosures, the FY27 outlook and the risks to watch. Univest readers can start with the Financial Highlights table that follows, which sets the consolidated figures against the same quarter last year.
Click Here – Get Free Investment Predictions
Artemis Medicare Services Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 311.04 Cr | Rs 274.7 Cr | +13.23% YoY |
| Operating Profit | Rs 54.82 Cr | Rs 50.62 Cr | +8.3% YoY |
| Net Profit (PAT) | Rs 31.1 Cr | Rs 30 Cr | +3.67% YoY |
Source: company filing for Artemis Medicare Services Q2 Results FY27, 30 October 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from Artemis Medicare Services Q2 Results: What Stands Out
- Revenue of Rs 311.04 Cr rose 13.23% YoY from Rs 274.7 Cr, the headline YoY growth figure in the Artemis Medicare Services Q2 Results FY27 release.
- Net profit of Rs 31.1 Cr compares with Rs 30 Cr in the same quarter last year, a rise of 3.67% on a consolidated basis.
- Operating Profit of Rs 54.82 Cr was up 8.3% YoY from Rs 50.62 Cr, a rate between the revenue and net profit growth.
- Net profit was down 0.7% quarter on quarter from Rs 31.31 Cr, the main sequential point among the disclosed risks.
- Return on capital employed was 15.83% in FY26, and the performance analysis below puts these figures in context.
Artemis Medicare Services Q2 Results FY27: Performance Analysis
Artemis Medicare Services reported consolidated revenue of Rs 311.04 Cr for July to September 2026, up 13.23% YoY from Rs 274.7 Cr, while net profit rose 3.67% YoY to Rs 31.1 Cr. The Artemis Medicare Services Q2 Results FY27 numbers therefore show revenue growing faster than profit over the year.
Operating Profit rose 8.3% YoY to Rs 54.82 Cr from Rs 50.62 Cr, so each profit line grew more slowly than revenue, with net profit showing the smallest YoY growth of the three. In this results analysis, that ordering is the clearest pattern in the quarterly results.
Investors tracking Artemis Medicare Services Q2 Results can note that net profit of Rs 31.1 Cr sits against Rs 31.31 Cr in the previous quarter, so the sequential and YoY pictures differ. The supplied figures confirm the results but do not establish the specific cause, which is where the results analysis turns to the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue Growth – The results analysis points first to revenue, which grew 13.2% year on year to Rs 311.04 Cr in the latest quarter, the top line behind every profit figure in the Artemis Medicare Services Q2 Results FY27 release.
Net Profit – Net profit rose 3.7% year on year to Rs 31.10 Cr, a smaller rise than revenue, so profit grew more slowly than sales in these quarterly results.
Return on Capital Employed – Return on capital employed was 15.83% in FY26, the disclosed measure of how the company's capital base earned over the last full financial year before this quarter.
FY27 Outlook After Artemis Medicare Services Q2 Results
Full-year FY27 results for Artemis Medicare Services will depend on the quarters still to be declared and on disclosed conditions. The Artemis Medicare Services Q2 Results FY27 figures give one quarter of consolidated revenue and net profit, and the results analysis should be read as a single data point within that year.
Net profit of Rs 31.1 Cr and revenue of Rs 311.04 Cr form the base against which later FY27 quarters will be read. The Univest Screener lets readers follow each new filing, and the risks below describe the disclosed figures to watch.
Key Risks to Watch After Artemis Medicare Services Q2 Results FY27
Sequential Dip in Net Profit
Net profit was down 0.7% quarter on quarter from Rs 31.31 Cr, even as the Artemis Medicare Services Q2 Results FY27 release shows a YoY rise, so the sequential trend is one figure for investors to watch in later filings.
Lower Return on Equity
Return on equity declined to 12.72% in FY26 from 14.43% in FY25, a disclosed decline that readers can set beside the YoY growth in profit reported for this quarter.
Lower Return on Capital Employed
Return on capital employed declined to 15.83% in FY26 from 16.93% in FY25, the second return measure in the disclosures that moved lower over the year and is worth tracking.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Artemis Medicare Services Q2 Results FY27 show consolidated revenue of Rs 311.04 Cr and net profit of Rs 31.1 Cr for July to September 2026, with a YoY rise in both. These quarterly results and consolidated results figures come from the 30 October 2026 declaration. Univest presents the Artemis Medicare Services Q2 Results data as a factual record, and investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Artemis Medicare Services Q2 Results FY27
What are Artemis Medicare Services Q2 Results FY27?
Ans. Artemis Medicare Services Q2 Results FY27 are the Consolidated quarterly results for July to September 2026, declared 30 October 2026. They show revenue of Rs 311.04 Cr and net profit of Rs 31.1 Cr, as the introduction covers.
What is the results date for Artemis Medicare Services Q2 Results FY27?
Ans. The results date for Artemis Medicare Services was 30 October 2026, covering July to September 2026, which matches the declaration date given in the Quick Answer and the opening paragraphs of this article.
What revenue was reported in Artemis Medicare Services Q2 Results FY27?
Ans. Artemis Medicare Services Q2 Results FY27 report revenue of Rs 311.04 Cr against Rs 274.7 Cr a year earlier, so the figure is up 13.23% YoY, as shown in the Financial Highlights table.
What net profit was reported in Artemis Medicare Services Q2 Results FY27?
Ans. Artemis Medicare Services reported net profit of Rs 31.1 Cr, compared with Rs 30 Cr a year earlier, which means a 3.67% rise, as detailed in the Key Takeaways section of this article.
How much YoY growth did revenue show in Artemis Medicare Services Q2 Results FY27?
Ans. Revenue showed YoY growth of 13.23% for Artemis Medicare Services, while the year-earlier base was Rs 274.7 Cr, as the Performance Analysis section explains alongside the net profit movement.
Did net profit rise or fall in Artemis Medicare Services Q2 Results?
Ans. Net profit rose in Artemis Medicare Services Q2 Results, from Rs 30 Cr to Rs 31.1 Cr, a 3.67% YoY increase, although it was down 0.7% from the previous quarter, as the risks section notes.
What was the Operating Profit in Artemis Medicare Services Q2 Results FY27?
Ans. Operating Profit for Artemis Medicare Services was Rs 54.82 Cr, up 8.3% from Rs 50.62 Cr a year earlier, which means it grew faster than net profit, as the Performance Analysis explains.
Are Artemis Medicare Services Q2 Results consolidated results or standalone results?
Ans. Artemis Medicare Services Q2 Results are consolidated results, so the figures cover the company on a consolidated basis, which means revenue of Rs 311.04 Cr and net profit of Rs 31.1 Cr reflect it, as the introduction states.
What business factors shaped Artemis Medicare Services Q2 Results FY27?
Ans. The disclosed factors are revenue growth of 13.2% to Rs 311.04 Cr, net profit up 3.7% and return on capital employed of 15.83% in FY26, as set out in the Key Business Factors section.
What are the key risks after Artemis Medicare Services Q2 Results FY27?
Ans. The key risks are a 0.7% quarter on quarter dip in net profit and lower FY26 returns on equity and capital employed, which means investors can track them as detailed in the Key Risks section.
What is the outlook after Artemis Medicare Services Q2 Results?
Ans. The outlook rests on later FY27 quarters, so full-year results will depend on subsequent declarations, as the FY27 Outlook section explains, alongside the revenue and net profit base set in this quarter.
Where can I find the complete Artemis Medicare Services Q2 Results FY27 data?
Ans. The complete data sits in the Financial Highlights table earlier in this article, alongside the Performance Analysis, which means every revenue, Operating Profit and net profit figure can be found in one place.
Recent Articles

Sarda Proteins Q2 Results FY27: Revenue Drops 81.16% to Rs 0.81 Cr, PAT Rs 0.14 Cr
31 October 2026

Dai-Ichi Karkaria Q2 Results FY27: Revenue Rises 26.45% to Rs 54.11 Cr, PAT Rs 0.90 Cr
31 October 2026

Shriram Pistons & Rings Q2 Results FY27: Revenue Jumps 62.14% YoY to Rs 1,648.20 Cr, PAT Rs 162.30 Cr
31 October 2026

Loyal Equipments Q2 Results FY27: Revenue Falls 12.34% to Rs 11.93 Cr, PAT Rs 0.81 Cr
31 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Sarda Proteins Q2 Results FY27: Revenue Drops 81.16% to Rs 0.81 Cr, PAT Rs 0.14 Cr
Dai-Ichi Karkaria Q2 Results FY27: Revenue Rises 26.45% to Rs 54.11 Cr, PAT Rs 0.90 Cr
Shriram Pistons & Rings Q2 Results FY27: Revenue Jumps 62.14% YoY to Rs 1,648.20 Cr, PAT Rs 162.30 Cr
Loyal Equipments Q2 Results FY27: Revenue Falls 12.34% to Rs 11.93 Cr, PAT Rs 0.81 Cr
Finolex Industries Q2 Results FY27: Profit Moves Against Revenue, Revenue Rs 1,093.96 Cr, PAT Rs 115.02 Cr
Popular this week
Tilaknagar Industries Q2 Results FY27: Revenue Jumps 172.76% to Rs 1,035.30 Cr, PAT Falls to Rs 22.27 Cr

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





